The state of global biotech: An Ernst & Young perspective
The United States is still a dominant player in global biotech sales, R&D, publicly traded companies, and other parameters, but the rest of the world is catching up. In this edition of Yer Biotech Blues, columnist Michael Rosen outlines this and other findings from the...